Severe hypoglycemia induces brain edema by upregulating aquaporin-4 (AQP4) expression and by degrading tight junctions. Acute severe hypoglycemia induces a proinflammatory environment that may contribute to a disruption in the epithelial barrier by decreasing tight junction protein expression. Interestingly, the altered AQP4 expression has been considered to play a critical role in neuroinflammation during acute brain injury. It has been shown that AQP4 deletion reduces brain inflammation in AQP4-null mice after intracerebral LPS injection. However, the effect of AQP4 deletion regarding protection against hypoglycemia-induced blood-brain barrier (BBB) breakdown is unknown. An acute severe hypoglycemic stress model was established via injection of 4 unit/kg body weight of insulin. Evans blue (EB) staining and water measurement were used to assess BBB permeability. Western blot, reverse transcription polymerase chain reaction, and immunofluorescence were used to detect the expression of related proteins. The production of cytokines was assessed via enzyme-linked immunosorbent assay. Hypoglycemia-induced brain edema and BBB leakage were reduced in AQP4−/− mice. AQP4 deletion upregulated PPAR-γ and inhibited proinflammatory responses. Moreover, knockdown of aquaporin-4 by small interfering RNA in astrocytes co-cultured with endothelial cells effectively reduced transendothelial permeability and degradation of tight junctions. Treatment with PPAR-γ inhibitors showed that upregulation of PPAR-γ was responsible for the protective effect of AQP4 deletion under hypoglycemic conditions. Our data suggest that AQP4 deletion protects BBB integrity by reducing inflammatory responses due to the upregulation of PPAR-γ expression and attenuation of proinflammatory cytokine release. Reduction in AQP4 may be protective in acute severe hypoglycemia.
Hypoxia inducible factor‐1α (HIF‐1α) is associated with human breast cancer chemoresistance. Various reports have suggested that multiple pathways are involved inHIF‐1α induction and that the molecular mechanisms regulatingHIF‐1α‐induced chemoresistance are still not fully understood. Here, we report that anterior gradient 2 (AGR2), a proposed breast cancer biomarker, is an essential regulator in hypoxia‐induced doxorubicin resistance through the binding and stabilization ofHIF‐1α. Our results show that knockdown ofAGR2 inMCF‐7 cells leads to the suppression ofHIF‐1α‐induced doxorubicin resistance, whereas elevated levels ofAGR2 inMDA‐MB‐231 cells enhanceHIF‐1α‐induced doxorubicin resistance.AGR2 expression, in turn, is upregulated by the hypoxic induction ofHIF‐1α at both translational and transcriptional levels via a hypoxia‐responsive region from −937 to −912 bp on theAGR2 promoter sequence. By specific binding toHIF‐1α, the increased level of intracellularAGR2 stabilizesHIF‐1α and delays its proteasomal degradation. Finally, we found thatAGR2‐stabilizedHIF‐1α escalates multiple drug resistance protein 1 (MDR1)mRNAlevels and limits doxorubicin intake ofMCF‐7 cells, whereasMCF‐7/ADR, a doxorubicin resistant cell line with deficientAGR2 andHIF‐1α, acquires wild‐typeMDR1 overexpression. Our findings, for the first time, describeAGR2 as an important regulator in chemical hypoxia‐induced doxorubicin resistance in breast cancer cells, providing a possible explanation for the variable levels of chemoresistance in breast cancers and further validatingAGR2 as a potential anti‐breast cancer therapeutic target.
Hypoglycemia-induced brain edema is a severe clinical event that often results in death. The mechanisms by which hypoglycemia induces brain edema are unclear. In a hypoglycemic injury model established in adult rats, brain edema was verified by measuring brain water content and visualizing water accumulation using hematoxylin and eosin staining. Temporal expression of aquaporin 4 (AQP4) and the integrity of the blood-brain barrier (BBB) were evaluated. We assessed the distribution and expression of AQP4 following glucose deprivation in astrocyte cultures. Brain edema was induced immediately after severe hypoglycemia but continued to progress even after recovery from hypoglycemia. Upregulation of AQP4 expression and moderate breakdown of the BBB were observed 24 h after recovery. In vitro, significant redistribution of AQP4 to the plasma membrane was induced following 6 h glucose deprivation. Hypoglycemia-induced brain edema is caused by cytotoxic and vasogenic factors. Changes in AQP4 location and expression may play a protective role in edema resolution.